01 1Bayer AG
01 1Bayer Korea Co., Ltd.
01 1Iopromide
01 1Germany
Registrant Name : Bayer Korea Co., Ltd.
Registration Date : 2018-07-06
Registration Number : 20180706-210-J-240
Manufacturer Name : Bayer AG
Manufacturer Address : Ernst-Schering-Straße 14 59192 Bergkamen Germany
59
PharmaCompass offers a list of Iopromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Iopromide manufacturer or Iopromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iopromide manufacturer or Iopromide supplier.
A iopromid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of iopromid, including repackagers and relabelers. The FDA regulates iopromid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. iopromid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of iopromid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A iopromid supplier is an individual or a company that provides iopromid active pharmaceutical ingredient (API) or iopromid finished formulations upon request. The iopromid suppliers may include iopromid API manufacturers, exporters, distributors and traders.
click here to find a list of iopromid suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a iopromid Drug Master File in Korea (iopromid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of iopromid. The MFDS reviews the iopromid KDMF as part of the drug registration process and uses the information provided in the iopromid KDMF to evaluate the safety and efficacy of the drug.
After submitting a iopromid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their iopromid API can apply through the Korea Drug Master File (KDMF).
click here to find a list of iopromid suppliers with KDMF on PharmaCompass.
